Defining an antimicrobial monitoring service

American Journal of Health-System Pharmacy

Volumn 65, Issue 22, 2008, Pages

  Baker, Catherine A ^a   Sehdev, Paul ^a  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; DRUG COST; DRUG INDICATION; DRUG MONITORING; DRUG USE; HIGH RISK PATIENT; MEDICAL SOCIETY; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 56749179661     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070665     Document Type: Short Survey

References (16)

1. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005; 18:638-56.
2. Owens RC Jr, Fraser GL, Stogsdill P et al. Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2004; 24:896-908.
3. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997; 24:471-85. Review.
4. Yates RR. New intervention strategies for reducing antibiotic resistance. Chest. 1999; 115(suppl 3):24S-7S.
5. Gums JG, Yancey RW Jr, Hamilton CA et al. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999; 19:1369-77.
6. Cadle RM, Darouiche RO, Tibbetts CS et al. Pharmacist's impact on antimicrobial drug therapy. Am J Health-Syst Pharm. 1995; 52:1544-6.
7. Gentry CA, Greenfield RA, Slater LN et al. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health-Syst Pharm. 2000; 57:268-74.
8. Feucht CL, Rict LB. An interventional program to improve antibiotic use. Ann Pharmacother. 2003; 37:646-51.
9. Gross R, Morgan AM, Kinky DE et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001; 33:289-95.
10. Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159-77.
11. Lawton RM, Fridkin SK, Gaynes RP et al. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 2000; 21:256-9.
12. Girouard S, Levine G, Goodrich K et al. Infection control programs at children's hospitals: a description of structures and processes. Am J Infect Control. 2001; 29:145-51.
13. Sunenshine RH, Liedtke LA, Jernigan DB et al. Role of infectious disease consultants in management of antimicrobial use in hospitals. Clin Infect Dis. 2004; 38:934-8.
14. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother. 1999; 44(suppl A):31-6.
15. Stosor V, Peterson LR, Postelnick M et al. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 1998; 158:522-7.
16. Edmond MB, Ober JF, Dawon JD et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis. 1996; 23:1234-9.